Results 231 to 240 of about 40,743 (286)
Some of the next articles are maybe not open access.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear.
Takeshi, Inoue +2 more
openaire +2 more sources
Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear.
Takeshi, Inoue +2 more
openaire +2 more sources
SSRI-to-SSRI Switching and Associated Dosing Characteristics
Journal of Managed Care Pharmacy, 1999OBJECTIVE: To evaluate antidepressant switching rates and associated dosing characteristics in patients undergoing therapy with one of the selective serotonin reuptake inhibitors (SSRls)-fluoxetine, paroxetine, or sertraline. DESIGN: A longitudinal, retrospective drug utilization analysis of administrative prescription claims for patients who initiated
openaire +1 more source
Complications of SSRI Treatment
Journal of Child and Adolescent Psychopharmacology, 2001EVEN THOUGH THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) have a very favorable side-effect profile, problems can develop during treatment that can cause concern. Complications of treatment that are easiest to deal with are those that are expected, occur early in the course of treatment, are mostly physical in nature, and either go away on their ...
J, Walkup, M, Labellarte
openaire +2 more sources
SSRIs: Are the accusations justified
The World Journal of Biological Psychiatry, 2004(2004). SSRIs: Are the accusations justified. The World Journal of Biological Psychiatry: Vol. 5, No. 4, pp. 174-175.
openaire +2 more sources
The SSRI discontinuation syndrome
Journal of Psychopharmacology, 1998A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves spontaneously within 3 weeks, and consists of diverse physical and psychological symptoms, the commonest being dizziness, nausea, lethargy and headache. SSRI reinstatement
openaire +2 more sources
Differences in interactions of SSRIs
International Clinical Psychopharmacology, 1998The SSRIs differ from each other with regard to their chemical structure, their pharmacokinetics and their potential for causing pharmacokinetic interactions through inhibition of species of the cytochrome P450 enzyme system. Cytochrome P450 (CYP) is a group of more than 30 different heme containing proteins in humans, some of which play a key role in ...
openaire +2 more sources
The Brown University Psychopharmacology Update, 2017
Depression frequently occurs in the setting of cardiovascular disease, including atrial fibrillation. Anticoagulants such as warfarin are commonly used in patients with atrial fibrillation in order to prevent the occurrence of stroke, while selective serotonin reuptake inhibitors (SSRIs), the mainstays of antidepressant pharmacology, have been ...
openaire +1 more source
Depression frequently occurs in the setting of cardiovascular disease, including atrial fibrillation. Anticoagulants such as warfarin are commonly used in patients with atrial fibrillation in order to prevent the occurrence of stroke, while selective serotonin reuptake inhibitors (SSRIs), the mainstays of antidepressant pharmacology, have been ...
openaire +1 more source